Maresin 1 induces resolution of hepatic fibrosis through RORα-dependent reprogramming of resident macrophages
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Hepatic fibrosis is a progressive pathological condition characterized by chronic inflammation and excessive extracellular matrix deposition (ECM), which may progress to cirrhosis and liver failure. Although specialized pro-resolving lipid mediators have emerged as potential therapeutic agents, their role in advanced hepatic fibrosis remains incompletely defined. This study aimed to determine whether Maresin 1 (MaR1), an endogenous pro-resolving lipid mediator, promotes the resolution of hepatic fibrosis and modulates the associated inflammatory response. Hepatic fibrosis was induced in mice and rats using diethylnitrosamine (DEN). Animals were subsequently treated with MaR1 or vehicle. Histological and biochemical parameters, apoptosis and proliferation markers, and immune profiles associated with hepatic macrophages polarization were assessed. Additionally, the expression and subcellular localization of retinoic acid related orphan receptor alpha (RORα) and nuclear factor kappa B (NF-κB p65) were analysed. MaR1 treatment significantly attenuated hepatic fibrosis, reduced the ECM accumulation, and promoted restoration of liver parenchyma, accompanied by decreased hepatocellular injury and enhanced regenerative capacity. MaR1 also induced immune reprogramming, favouring anti-inflammatory and homeostatic macrophage phenotypes. These effects were associated with increased nuclear activation of RORα and modulation of NF-κB signalling pathways. These findings demonstrate that MaR1 promotes the resolution of hepatic fibrosis through macrophage polarization and modulation of the RORα/NF-κB axis. This study advances the understanding of pro-resolving mechanisms in hepatic fibrosis and positions MaR1 as a pharmacologically relevant candidate for the development of targeted antifibrotic therapies in chronic liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“…cells exhibit marked phenotypic plasticity and can adopt a proinflammatory phenotype (M1), characterized by the production of cytokines such as tumour necrosis factor-alpha (TNF-α ) and interleukin-1 beta (IL-1 β ) (Mosser and Edwards, 2008), thereby exacerbating tissue damage and fibrogenesis.”
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 1×
“In contrast, MoMas are recruited from the bone marrow (BM) in response to chemoattractants and, once in the parenchyma, can engage in proinflammatory or reparative functions, depending on the microenvironment (Wynn et al., 2013) .”
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481 · cited 1×
“Macrophages are pivotal regulators of liver injury, fibrogenesis, and tissue repair (Wynn and Vannella, 2016).”
Yunna, C., Mengru, H., Lei, W., & Weidong, C. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173090 · Cited by 2,454
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024 · cited 1×
“This regression involves a series of mechanisms such as modulation of the inflammatory microenvironment, degradation of the ECM, reduction of oxidative stress and regeneration of hepatocytes (Arthur, 2001; Caligiuri et al., 2021; Kisseleva and Brenner, 2020).”
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780 · cited 1×
“It is characterized by an excessive scarring response that develops following sustained hepatic injury and chronic inflammation, leading to the accumulation of extracellular matrix (ECM) and distortion of liver architecture (Friedman, 2003).”
InfluentialLiver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424 · cited 1×
“The dynamic balance between these macrophage activation states is therefore critical for determining of whether liver injury progresses toward fibrosis or undergoes resolution (Krenkel and Tacke, 2017).”
Jetten, A. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07003 · Cited by 673 · cited 2×
“Accordingly, it is reasonable to propose that MaR1 exerts part of its immunomodulatory and metabolic effects through ROR α activation (Jetten, 2009).”
M1/M2 macrophages and their overlaps – myth or reality?
Strizova, Z., Benesova, I., Bartolini, R., Novysedlak, R., Cecrdlova, E., Foley, L. K., & Striz, I. (2023) · Clinical Science · doi:10.1042/cs20220531 · Cited by 612 · cited 1×
“In fact, several studies have suggested a broader and more dynamic functional spectrum of intermediate states between M1 and M2, which are induced depending on the balance of inflammatory, metabolic, and tissue stimuli (Strizova et al., 2023).”
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581 · cited 1×
“Nevertheless, this classification hinders a comprehensive understanding of the diverse macrophage phenotypes, especially in an organ with such distinctive architecture and functions as the liver (Gao C. C. et al., 2022; Wang et al., 2021).”
Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
Gao, J., Liang, Y., & Wang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888713 · Cited by 555
Role of Kupffer cells in the pathogenesis of liver disease
Kolios, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i46.7413 · Cited by 505 · cited 1×
“Similarly, it has been documented in other liver pathologies, such as alcoholism and fibrosis, that both KCs and MoMas sustain a chronic low-grade inflammatory state associated with persistent tissue damage (Kolios et al., 2006; Ran et al., 2024).”
The nuclear receptor superfamily: A structural perspective
Weikum, E. R., Liu, X., & Ortlund, E. A. (2018) · Protein Science · doi:10.1002/pro.3496 · Cited by 495 · cited 1×
“In parallel, nuclear receptors play a central role in integrating metabolic and inflammatory signalling pathways that govern liver homeostasis (Weikum et al., 2018).”
Tosello-Trampont, A.-C., Landes, S. G., Nguyen, V., Novobrantseva, T. I., & Hahn, Y. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417014 · Cited by 415
Friedman, S. L. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.013 · Cited by 350 · cited 1×
“Fibrosis is a central pathological feature of chronic liver diseases and represents a major determinant of progression toward cirrhosis and liver failure (Friedman, 2008).”
Yoshikawa, T., Ide, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Matsuzaka, T., Yatoh, S., Kitamine, T., Okazaki, H., Tamura, Y., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0190 · Cited by 297
The orphan nuclear receptor RORα is a negative regulator of the inflammatory response
Delerive, P., Monté, D., Dubois, G., Trottein, F., Fruchart‐Najib, J., Mariani, J., Fruchart, J., & Staels, B. (2001) · EMBO reports · doi:10.1093/embo-reports/kve007 · Cited by 286 · cited 1×
“Moreover, ROR α has been reported to stabilize I κ B α and interfere with protein kinase complex (IKK) complexes activity, thereby limiting NF-κ B nuclear translocation and transcriptional output (Delerive et al., 2001; Kim et al., 2023).”
Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N. (2013) · The FASEB Journal · doi:10.1096/fj.13-227728 · Cited by 283
Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S., & Marra, F. (2021) · Cells · doi:10.3390/cells10102759 · Cited by 270
Kupffer Cell Metabolism and Function.
Nguyen‐Lefebvre, A. T., & Horuzsko, A. (2015) · PubMed · Cited by 241
Microglial UCP2 mediates inflammation and obesity induced by high-fat feeding
Kim, J. D., Yoon, N. A., Jin, S., & Diano, S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.010 · Cited by 240 · cited 1×
“This finding is particularly relevant because M0 macrophages represent a non-polarized and highly plastic state, capable of differentiating in response to microenvironmental cues towards either inflammatory or reparative phenotypes (Kim et al., 2019).”
JNK mediates hepatic ischemia reperfusion injury
Uehara, T., Bennett, B., Sakata, S. T., Satoh, Y., Bilter, G. K., Westwick, J. K., & Brenner, D. A. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.01.030 · Cited by 214 · cited 1×
“JNK is activated in response to stress signals, such as stimulation or production of proinflammatory cytokines, including TNF-α , following activation of KCs (Lentsch et al., 1999; Uehara et al., 2005).”
Management Strategies for Liver Fibrosis
Altamirano-Barrera, A., Barranco-Fragoso, B., & Méndez-Sánchez, N. (2017) · Annals of Hepatology · doi:10.5604/16652681.1226814 · Cited by 191
Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice
Laiglesia, L. M., Lorente-Cebrián, S., Martínez-Fernández, L., Sáinz, N., Prieto-Hontoria, P. L., Burrell, M. A., Rodríguez-Ortigosa, C. M., Martínez, J. A., & Moreno-Aliaga, M. J. (2018) · International Journal of Obesity · doi:10.1038/ijo.2017.226 · Cited by 167 · cited 1×
“MaR1 has demonstrated beneficial effects in metabolic disorders, including obesity, insulin resistance, and hepatic steatosis (Laiglesia et al., 2018; Martínez-Fernández et al., 2017), and has been shown to drive macrophage polarization toward reparative phenotypes (Bi et al., 2019; Qiao et al.,…”
Han, Y.-H., Shin, K.-O., Kim, J.-Y., Khadka, D. B., Kim, H.-J., Lee, Y.-M., Cho, W.-J., Cha, J.-Y., Lee, B.-J., & Lee, M.-O. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124219 · Cited by 154 · cited 2×
“Although MaR1-mediated ROR α activation has been reported in metabolic liver disease models (Han et al., 2019), the mechanisms by which this axis operates in advanced liver disease remain poorly characterized (Nematisouldaragh et al., 2024).”
Han, Y.-H., Kim, H.-J., Na, H., Nam, M.-W., Kim, J.-Y., Kim, J.-S., Koo, S.-H., & Lee, M.-O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.017 · Cited by 150 · cited 1×
“In diet-induced liver inflammation models, pharmacological or antibody-mediated activation of ROR α increased hepatic M2/ M1 ratios, reduced oxidative stress and normalized metabolic parameters (Han et al., 2017; Han et al., 2019).”
M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment
Bi, Y., Chen, J., Hu, F., Liu, J., Li, M., & Zhao, L. (2019) · Neural Plasticity · doi:10.1155/2019/6724903 · Cited by 150 · cited 1×
“…beneficial effects in metabolic disorders, including obesity, insulin resistance, and hepatic steatosis (Laiglesia et al., 2018; Martínez-Fernández et al., 2017), and has been shown to drive macrophage polarization toward reparative phenotypes (Bi et al., 2019; Qiao et al., 2020; Zhu et al., 2016).”
Cytochrome P450-derived eicosanoids and heart function
Jamieson, K. L., Endo, T. H., Darwesh, A. M., Samokhvalov, V., & Seubert, J. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.005 · Cited by 128 · cited 1×
“…proliferator-activated receptor alpha (PPAR α ) is a well-established regulator of hepatic fatty acid β -oxidation and inflammatory control (Pawlak et al., 2015), underscoring the importance of the nuclear receptor network in shaping the hepatic immunometabolic environment (Jamieson et al., 2017).”
Lentsch, A. B., Yoshidome, H., Kato, A., Warner, R. L., Cheadle, W. G., Ward, P. A., & Edwards, M. J. (1999) · Hepatology · doi:10.1002/hep.510300615 · Cited by 105 · cited 9×
“KCs located in hepatic sinusoids are involved in basal immune surveillance and are crucial as detectors of initial injury, as well as initiators of an inflammatory cascade within the liver (Nguyen-Lefebvre and Horuzsko, 2015).”
InfluentialMartínez-Fernández, L., González-Muniesa, P., Laiglesia, L. M., Sáinz, N., Prieto-Hontoria, P. L., Escoté, X., Odriozola, L., Corrales, F. J., Arbones-Mainar, J. M., Martínez, J. A., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600859r · Cited by 105
Macrophage in liver Fibrosis: Identities and mechanisms
Wang, Z., Du, K., Jin, N., Tang, B., & Zhang, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110357 · Cited by 105 · cited 1×
“While M1 macrophages exacerbate liver injury and fibrosis, M2 polarization has been associated with the resolution of fibrosis, ECM remodelling, and the restoration of liver homeostasis (Wang et al., 2023).”
Docosahexaenoic acid enhances M2 macrophage polarization via the p38 signaling pathway and autophagy
Kawano, A., Ariyoshi, W., Yoshioka, Y., Hikiji, H., Nishihara, T., & Okinaga, T. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28527 · Cited by 91 · cited 5×
“DHA has also been reported to induce M2 polarization in macrophages; for example, in vitro studies using MoMas showed that DHA treatment increased the expression of CD206, Arg1 and IL-10 (Kawano et al., 2019).”
InfluentialSun, S., Wang, J., Wang, J., Wang, F., Yao, S., & Xia, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01323 · Cited by 87 · cited 1×
“…been widely explored in liver fibrosis, previous studies have showed that MaR1 modulates MAPK pathways in different tissue injury models, such as renal injury and sepsis, suggesting a protective role mediated through the inhibition of these signalling pathways (Dai et al., 2025; Sun et al., 2019).”
Han, Y.-H., Kim, H.-J., Kim, E.-J., Kim, K.-S., Hong, S., Park, H.-G., & Lee, M.-O. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5655 · Cited by 84
Activation of orphan receptor‐mediated transcription by Ca2+/calmodulin‐dependent protein kinase IV
Kane, C. D., & Means, A. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.691 · Cited by 84 · cited 1×
“Competition for transcriptional coactivators, such as p300, may further contribute to this regulatory effect (Kane and Means, 2000).”
Diet and risk of ethanol-induced hepatotoxicity: carbohydrate-fat relationships in rats
Korourian, S., Hakkak, R., Ronis, M. J. J., Shelnutt, S. R., Waldron, J. A., Ingelman‐Sundberg, M., & Badger, T. M. (1999) · Toxicological Sciences · doi:10.1093/toxsci/47.1.110 · Cited by 81 · cited 1×
“Histological scoring was performed in duplicate on five random fields per section using the Korourian score (Korourian et al., 1999).”
Boer, A. A. D., Monk, J. M., & Robinson, L. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085037 · Cited by 77 · cited 1×
“In LPS-induced murine inflammation, MaR1 more efficiently upregulated CD206 and reparative mediators, highlighting its superior capacity to resolve inflammation and promote tissue repair (De Boer et al., 2014).”
Maresin 1 Promotes Wound Healing and Socket Bone Regeneration for Alveolar Ridge Preservation
Wang, C., Yu, S. H., Fretwurst, T., Larsson, L., Sugai, J. V., Oh, J., Lehner, K. A., Jin, Q., & Giannobile, W. V. (2020) · Journal of Dental Research · doi:10.1177/0022034520917903 · Cited by 69 · cited 1×
“In this way, previously it was reportted that MaR1 increases the population of CD206 + macrophages during reparative processes such as dermal wound healing and alveolar bone regeneration (Wang et al., 2020).”
RORα controls inflammatory state of human macrophages
Moharrami, N. N., Tande, E. B., Ryan, L., Espevik, T., & Boyartchuk, V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207374 · Cited by 66
Videla, L. A., Valenzuela, R., del Campo, A., & Zúñiga‐Hernández, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115528 · Cited by 58 · cited 2×
“Recently, it has been highlighted the role of MaR1 in MAFLD pathophysiology (Videla et al., 2023), and clinical studies have reported reduced serum levels in patients with MAFLD patients (Tang et al., 2021).”
Maresin-1 resolution with RORα and LGR6
Im, D. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101034 · Cited by 48 · cited 2×
“Interestingly, while ROR α is classically described as a monomeric nuclear receptor (Im, 2020), our findings suggest a potential interaction between ROR α and the p65 subunit of NF-κ B under chronic inflammation conditions.”
Dose-Related Induction of Hepatic Preneoplastic Lesions by Diethylnitrosamine in C57BL/6 Mice
Kushida, M., Kamendulis, L. M., Peat, T. J., & Klaunig, J. E. (2011) · Toxicologic Pathology · doi:10.1177/0192623311409596 · Cited by 44 · cited 1×
“C57BL/6 mice received DEN at 25 mg/kg following the same administration schedule (Kushida et al., 2011).”
Ou, Z., Shi, X., Gilroy, R. K., Kirisci, L., Romkes, M., Lynch, C., Wang, H., Xu, M., Jiang, M., Ren, S., et al. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1145 · Cited by 38 · cited 1×
“Clinical and experimental evidence indicates that ROR α expression is reduced in metabolic dysfunction-associated steatotic liver disease (MAFLD) and dysfunction-associated steatohepatitis (MASH) (Han et al., 2014; Ou et al., 2012).”
Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats
He, J., Bai, K., Hong, B., Zhang, F., & Zheng, S. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.09.013 · Cited by 38 · cited 1×
“Interestingly, studies have shown that DHA and its derivative MaR1 induce important antifibrotic effects in experimental models of liver disease (He et al., 2017; Rodríguez et al., 2021).”
Qiao, N., Lin, Y., Wang, Z., Chen, J., Ge, Y.-Y., Yao, S., & Gong, J. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.06.062 · Cited by 38 · cited 2×
“…M2 macrophages was not observed at the end of the experimental period, this may reflect an early polarization event followed by stabilization of macrophages in a plastic, functionally competent state, sufficient to maintain resolution without persistent activation (Qiao et al., 2020).”
The versatility of macrophage heterogeneity in liver fibrosis
Gao, C.-C., Bai, J., Han, H., & Qin, H.-Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968879 · Cited by 37
Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway
Tang, D., Fu, G., Li, W., Sun, P., Loughran, P., Deng, M., Scott, M. J., & Billiar, T. R. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00280-9 · Cited by 35 · cited 3×
“Recently, it has been highlighted the role of MaR1 in MAFLD pathophysiology (Videla et al., 2023), and clinical studies have reported reduced serum levels in patients with MAFLD patients (Tang et al., 2021).”
Zhang, M., Barroso, E., Peña, L., Rada, P., Valverde, Á. M., Wahli, W., Palomer, X., & Vázquez‐Carrera, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117303 · Cited by 34
Key role of macrophages in the progression of hepatic fibrosis
Ran, J., Yin, S., Issa, R., Zhao, Q., Zhu, G., Zhang, H., Zhang, Q., Wu, C., & Li, J. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000602 · Cited by 31 · cited 1×
“Similarly, it has been documented in other liver pathologies, such as alcoholism and fibrosis, that both KCs and MoMas sustain a chronic low-grade inflammatory state associated with persistent tissue damage (Kolios et al., 2006; Ran et al., 2024).”
Wang, F., Yang, G., Chen, T., Li, B., Zhang, W., Yin, L., Zhào, H., Tang, Y., Wang, X., & Huang, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109369 · Cited by 30 · cited 2×
“…found in the kidney and heart support its potential as a multi-organ therapeutic agent, as indicated by previous evidence of its protective effects in acute kidney injury ( via NOX4/ROS/NF-κ B p65) (Li et al., 2021) and myocardial infarction ( via Nrf2/HO-1 and TLR4/NF-κ B) (Wang et al., 2022).”
Xiao, L., Zhang, Z., Luo, X., Yang, H., Li, F., & Wang, N. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.10.006 · Cited by 29
Kim, E., Mawatari, K., Yoo, S. H., & Chen, Z. (2023) · Nutrients · doi:10.3390/nu15183919 · Cited by 21 · cited 1×
“Moreover, ROR α has been reported to stabilize I κ B α and interfere with protein kinase complex (IKK) complexes activity, thereby limiting NF-κ B nuclear translocation and transcriptional output (Delerive et al., 2001; Kim et al., 2023).”
The Role of Retinoic-Acid-Related Orphan Receptor (RORs) in Cellular Homeostasis
Nematisouldaragh, D., Kirshenbaum, E., Uzonna, M., Kirshenbaum, L. A., & Rabinovich-Nikitin, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111340 · Cited by 21
Zahoor, I., Nematullah, M., Ahmed, M. E., Fatma, M., Sajad, M., Ayasolla, K., Cerghet, M., Palaniyandi, S. S., Ceci, V., Carrera, G., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108226 · Cited by 21
Tratamiento de la fibrosis hepática
Domínguez, M., Colmenero, J., & Bataller, R. A. (2009) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2009.02.015 · Cited by 15 · cited 1×
“Hepatic fibrosis is a pathology that, if not treated timely, can evolve into cirrhosis and liver failure (Domínguez et al., 2009).”
Guo, Y., Xu, C., Fang, Y., Wang, C., Gao, N., Wen, Q., & Qiao, H. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23029 · Cited by 14 · cited 1×
“…intraperitoneal (i.p.) administration of DEN (Cat No. 73861, Sigma-Aldrich, Merck, Darmstadt, Germany) at a dose of 50 mg/kg body weight, two times a week for a period of 4 weeks and then once weekly for an additional 5 weeks, according to the DEN-induced hepatic fibrosis model (Guo et al., 2019).”
Dai, M., Sun, S., Dai, Y., Dou, X., Yang, J., Chen, X., Dong, Y., & Lin, Y. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04280-z · Cited by 10 · cited 1×
“…been widely explored in liver fibrosis, previous studies have showed that MaR1 modulates MAPK pathways in different tissue injury models, such as renal injury and sepsis, suggesting a protective role mediated through the inhibition of these signalling pathways (Dai et al., 2025; Sun et al., 2019).”
Cheng, K., Liu, K., Liu, S., Zhao, Y., & Wang, Q. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113030 · Cited by 7 · cited 1×
“ROR α also induce peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 α ) expression, a master regulator of mitochondrial biogenesis and metabolic homeostasis, thereby amplifying anti-inflammatory transcriptional programs (Cheng et al., 2024).”
Mechanisms of Progression and Regression of Liver Fibrosis
Arthur, M. J. P. (2001) · Springer eBooks · doi:10.1007/978-4-431-68343-8_1 · Cited by 2 · cited 1×
“This regression involves a series of mechanisms such as modulation of the inflammatory microenvironment, degradation of the ECM, reduction of oxidative stress and regeneration of hepatocytes (Arthur, 2001; Caligiuri et al., 2021; Kisseleva and Brenner, 2020).”
Research works printed but not linked: 8
- Beljaars, 2014, Hepatic localization of macrophage phenotypes during fibrogenesis and resolution of fibrosis in mice and humans, Front. Immunol., 5, 109533, 10.3389/FIMMU.2014.00430/BIBTEX · doi:10.3389/fimmu.2014.00430/bibtex
- Freedman, 2020, Biosynthesis of the maresin intermediate, 13S,14S-Epoxy-DHA, by human 15-Lipoxygenase and 12-Lipoxygenase and its regulation through negative allosteric modulators, Biochemistry, 59, 1832, 10.1021/acs.biochem.0c00233/suppl_file/bi0c00233_si_001.pdf · doi:10.1021/acs.biochem.0c00233/suppl_file/bi0c00233_si_001.pdf
- Li, 2021, Maresin 1 attenuates lipopolysaccharide-induced acute kidney Injury via inhibiting NOX4/ROS/NF-κB pathway, Front. Pharmacol., 12, 782660, 10.3389/FPHAR.2021.782660/BIBTEX · doi:10.3389/fphar.2021.782660/bibtex
- Pawlak, 2015, Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease, J. Hepatology, 62, 720, 10.1016/j.jhep.2014.10.039/asset/564df50d-33ea-4270-a683-3de59ea00476/main.assets/gr3.jpg · doi:10.1016/j.jhep.2014.10.039/asset/564df50d-33ea-4270-a683-3de59ea00476/main.assets/gr3.jpg
- Rodríguez, 2021, Maresin-1 prevents liver fibrosis by targeting Nrf2 and NF-κB, reducing oxidative stress and inflammation, Cells, 10, 3406, 10.3390/cells10123406/s1 · doi:10.3390/cells10123406/s1
- Shamsan, 2024, The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review, Front. Med., 11, 1389329, 10.3389/fmed.2024.1389329/pdf · doi:10.3389/fmed.2024.1389329/pdf
- Zhang, 2022, An M0 macrophage-related prognostic model for hepatocellular carcinoma, BMC Cancer, 22, 1, 10.1186/s12885-022-09872-y/figures/8 · doi:10.1186/s12885-022-09872-y/figures/8
- Zhu, 2016, Pro-resolving lipid mediators improve neuronal survival and increase Aβ42 phagocytosis, Mol. Neurobiol., 53, 2733, 10.1007/s12035-015-9544-0/figures/9 · doi:10.1007/s12035-015-9544-0/figures/9
Cited by
Endogenous Lipid Signals in Energy Homeostasis and Fibrosis
Meo, C. D., Palaniappan, S., Urbano, C., Cimino, G., Cestra, F., Dominicis, N. D., Carnicelli, V., Tisi, A., & Maccarrone, M. (2026) · Biomolecules · doi:10.3390/biom16081170
Martin, M. Q. S., Olivera-Fuentes, C., Vielma, F. H., Norambuena-González, R., Solís-Céspedes, E., González, D. R., Perera-Sardiña, Y., & Zúñiga‐Hernández, J. (2026) · Biomolecules · doi:10.3390/biom16111558
Self-citation
Metadata
- Authors
- Herrera Vielma, F., Quiñones San Martin, M., Muñoz-Carrasco, N., Berrocal-Navarrete, F., Herrada, A. A., Olate-Briones, A., Zagmutt, S., Rodríguez-Rodríguez, R., González, D. R., & Zúñiga-Hernandez, J.
- Affiliations
- Pharmacology Laboratory, Biomedical Sciences Department, Faculty of Health Sciences, University of Talca
- Universidad de Talca (CL)
- University of Concepción (CL)
- Lymphatic Vasculature and Inflammation Research Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, Universidad de Concepción
- Universitat Internacional de Catalunya (ES)
- Basic Sciences Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2026-04-27
- Volume
- 17
- Pages
- 1826739-1826739
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC13158560
- OpenAlex
- W7156374301
- Cited by
- 2
- References
- 58
- Citations by year
- 2026: 2
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Keywords
- maresin 1, liver fibrosis, RORα, NF-κB signaling, hepatic macrophages, macrophage polarization, specialized pro-resolving mediators, extracellular matrix deposition, antifibrotic therapy, chronic liver disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.